In addition, because a few compounds have been explored to modulate SIRT3 activity [27, 28], we also attempted to identify effective compounds that increase the endogenous SIRT3 modulation mediated by the anti-cancer effect of sorafenib. The gene discussed is SIRT3; the disease is cancer.